查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2022760

雨生紅球藻全球市場（按產品、應用和地區分類）：預測（至 2036 年）

Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients; Astaxanthin Bulk Finished Products ); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 290 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

全球雨生紅球藻市場預計將從2026年的1.164億美元成長至2036年的3.488億美元，預測期間（2026-2036年）複合年成長率（CAGR）為11.6%。以產量計算，市場規模預計將從2026年的682噸成長至2036年的約2,693噸，複合年成長率為13.0%。市場成長的主要促進因素包括：營養保健品和膳食補充劑領域對天然蝦青素的需求不斷成長；天然色素和潔淨標示成分的需求不斷成長；以及水產養殖和動物營養領域對天然蝦青素的日益廣泛應用。

雨生紅球藻是一種淡水微藻類，是目前已知最豐富的天然蝦青素來源，其乾生物量中可累積高達3-5%的這種強效酮類胡蘿蔔素。研究表明，雨生紅球藻中的天然蝦蝦青素的抗氧化能力遠遠超過維生素C和維生素E等傳統抗氧化劑。推動市場成長的關鍵因素包括消費者對天然類胡蘿蔔素健康益處的認知不斷提高，以及下游產業在全球範圍內從合成抗氧化劑轉向天然、潔淨標示抗氧化劑。儘管高昂的生產成本和複雜的培養過程仍然是挑戰，但光生物反應器技術的進步以及在機能性食品和飲料領域應用的不斷拓展有望帶來巨大的成長機會。

目錄

第1章：引言

第2章 分析方法

第3章執行摘要

  • 市場分析：按產品分類
  • 市場分析：按應用領域
  • 市場分析：按地區分類
  • 競爭分析

第4章 市場洞察

  • 市場促進因素
    • 營養保健品和膳食補充劑對天然蝦青素的需求日益成長
    • 消費者對天然食用色素和潔淨標示成分的需求日益成長。
    • 擴大天然蝦青素在水產養殖和動物營養的應用。
    • 抗衰老和防紫外線特性推動了化妝品應用範圍的擴大。
    • 越來越多的研究支持蝦青素對健康的益處。
  • 市場限制因素
    • 天然蝦青素生產成本高
    • 複雜的培養與萃取過程
  • 市場機遇
    • 光生物反應器培養技術的進展
    • 在機能性食品和飲料領域的應用拓展
    • 化妝品和個人保健產品。
  • 市場挑戰
    • 水產養殖領域與合成蝦蝦青素的競爭
    • 供應鏈限制和生產擴充性
  • 市場趨勢
    • 封閉式光生物反應器生產系統的擴展
    • 微膠囊化與穩定化技術的發展
    • 運動營養領域對天然蝦青素的需求日益成長。
  • 波特五力分析
  • 價值鏈分析
    • 菌株開發及接種物製備
    • 水產養殖（開放式池塘、封閉式光生物反應器系統）
    • 收穫和生質能加工
    • 蝦青素的萃取與純化
    • 配方和包裝
    • 分銷和最終用途

第5章：雨生紅球菌市場評估：依產品分類

  • 蝦青素素原料
    • 蝦青素樹脂
    • 珠
    • 生質能粉末
    • 水溶性粉末
  • 蝦青素製劑
    • 膠囊/軟膠囊
    • 藥片
    • 液體

第6章：雨生紅球藻市場評估：依應用領域

  • 營養保健品 - 膳食補充劑
  • 水產養殖/動物飼料
  • 化妝品和個人護理
  • 食品/飲料
  • 製藥

第7章：血球菌市場分析：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 丹麥
    • 瑞典
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東和非洲
    • 以色列
    • 埃及
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他中東和非洲國家

第8章 競爭情勢

  • 關鍵成長策略
  • 競爭性標竿分析
  • 競爭對手儀錶板
    • 產業領導者
    • 市場差異化因素
    • 先鋒公司
    • 新興企業
  • 市佔率分析

第9章：公司簡介

  • EID-Parry（India）Limited/Parry Nutraceuticals
  • Cyanotech Corporation
  • AstaReal Group/Fuji Chemical Industries
  • Algatech Ltd.（Solabia Group）
  • Algalif Iceland ehf.
  • Beijing Gingko Group（BGG）
  • Yunnan Alphy Biotech Co., Ltd.
  • Yunnan Green A Biological Project Co., Ltd.
  • Tianjin Norland Biotech Co., Ltd.
  • Sun Chlorella Corporation
  • BDI BioLife Science GmbH
  • Atacama Bio Natural Products SA
  • Shaivaa Algaetech LLP
  • PIVEG, Inc.
  • Others

第10章附錄

簡介目錄
Product Code: MRFB - 104446

Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder}; Astaxanthin Bulk Finished Products {Capsules/Softgels, Tablets}); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036

According to the research report titled, 'Haematococcus Pluvialis Market by Product (Astaxanthin Ingredients {Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder}; Astaxanthin Bulk Finished Products {Capsules/Softgels, Tablets}); Application (Nutraceuticals, Aquaculture & Animal Feed, Cosmetics, Food & Beverages, Pharmaceuticals), and Geography - Global Forecast to 2036,' the global Haematococcus pluvialis market is projected to reach USD 348.8 million by 2036 from USD 116.4 million in 2026, growing at a CAGR of 11.6% during the forecast period (2026-2036). In terms of volume, the market is expected to expand from 682 tons in 2026 to approximately 2,693 tons by 2036, at a CAGR of 13.0%. The growth of this market is primarily driven by the increasing demand for natural astaxanthin in nutraceuticals and dietary supplements, the growing demand for natural food colorants and clean-label ingredients, and the rising adoption of natural astaxanthin in aquaculture and animal nutrition.

Haematococcus pluvialis is a freshwater green microalga recognized as the most prolific natural source of astaxanthin, capable of accumulating this potent ketocarotenoid up to 3-5% of its dry biomass weight. Natural astaxanthin derived from H. pluvialis is documented to be exponentially stronger than traditional antioxidants like vitamin C and vitamin E. A major driver for the market is the global transition from synthetic to natural, clean-label antioxidant ingredients across downstream industries, supported by growing consumer awareness of the health benefits of natural carotenoids. While high production costs and complex cultivation processes remain challenges, advancements in photobioreactor technology and expanding applications in functional foods and beverages are expected to provide significant growth opportunities.

Market Segmentation

The global Haematococcus pluvialis market is segmented by product (astaxanthin ingredients and astaxanthin bulk finished products), application (nutraceuticals, aquaculture & animal feed, cosmetics, food & beverages, and pharmaceuticals), and geography. The study also evaluates industry competitors and analyzes the market at the country level.

Based on Product

By product, the astaxanthin ingredients segment is expected to hold the largest share of the global Haematococcus pluvialis market in 2026. This segment includes oleoresin, beadlets, whole biomass powder, and water-dispersible powder, which are widely used as upstream inputs in nutraceutical, food, cosmetic, and feed formulations. However, the astaxanthin bulk finished products segment-comprising capsules, softgels, and tablets-is projected to register faster growth during the forecast period, driven by the increasing consumer preference for ready-to-consume antioxidant supplements.

Based on Application

By application, the nutraceuticals segment is expected to account for the largest share of the market in 2026. This dominance is attributed to the extensive use of natural astaxanthin as a dietary supplement ingredient for cardiovascular, eye, and skin health. The pharmaceuticals segment is projected to register the highest CAGR during the forecast period, fueled by increasing research into the therapeutic potential of astaxanthin for inflammation management and neuroprotection. The cosmetics and personal care segment is also witnessing significant traction, particularly in anti-aging and skin protection formulations.

Geographic Analysis

In 2026, North America is expected to account for the largest share of the global Haematococcus pluvialis market. The region's leadership is driven by strong consumer demand for natural dietary supplements, a well-established nutraceutical industry, and favorable regulatory acceptance of H. pluvialis-derived astaxanthin. The U.S. remains the primary market, characterized by high consumer awareness of preventive healthcare. The key companies operating in the North America market include Cyanotech Corporation (U.S.) and PIVEG, Inc. (U.S.).

Asia-Pacific is projected to register the fastest CAGR during the forecast period. This growth is fueled by the massive expansion of microalgae cultivation capacity in China and the growing adoption of natural astaxanthin in nutraceutical and functional food applications across India, Japan, and South Korea. Rising investments in advanced photobioreactor systems are supporting regional market growth. The key companies operating in the Asia-Pacific market include E.I.D.-Parry (India) Limited / Parry Nutraceuticals, Beijing Gingko Group (BGG) (China), and Yunnan Alphy Biotech Co., Ltd. (China).

Europe remains a critical market, driven by the increasing demand for natural food colorants and the stringent EU regulations on synthetic additives. The region is a hub for high-purity microalgae production, particularly in Iceland and Germany. The key companies operating in the Europe market include Algalif Iceland ehf. (Iceland) and BDI BioLife Science GmbH (Austria).

Key Players

The key players operating in the global Haematococcus pluvialis market include E.I.D.-Parry (India) Limited / Parry Nutraceuticals (India), Cyanotech Corporation (U.S.), AstaReal Group / Fuji Chemical Industries (Japan), Algatech Ltd. (Solabia Group) (Israel), Algalif Iceland ehf. (Iceland), Beijing Gingko Group (BGG) (China), Yunnan Alphy Biotech Co., Ltd. (China), Yunnan Green A Biological Project Co., Ltd. (China), Tianjin Norland Biotech Co., Ltd. (China), Sun Chlorella Corporation (Japan), BDI BioLife Science GmbH (Austria), Atacama Bio Natural Products S.A. (Chile), Shaivaa Algaetech LLP (India), and PIVEG, Inc. (U.S.).

Key Questions Answered in the Report-

  • What is the value of revenue generated from the global Haematococcus pluvialis market?
  • At what rate is the Haematococcus pluvialis market demand projected to grow for the next 10 years?
  • What are the historical market sizes and growth rates of the Haematococcus pluvialis market?
  • What are the major factors impacting the growth of this market? What are the major opportunities for existing players and new entrants in the market?
  • Which segments in terms of product and application are expected to create major traction for the vendors in this market?
  • What are the key geographical trends in this market? Which regions/countries are expected to offer significant growth opportunities for the companies operating in the Haematococcus pluvialis market?
  • Who are the major players in the Haematococcus pluvialis market? What are their specific product offerings in this market?
  • What are the recent strategic developments in the Haematococcus pluvialis market? What are the impacts of these strategic developments on the market?

Scope of the Report:

  • Haematococcus Pluvialis Market Assessment -- by Product

Astaxanthin Ingredients (Astaxanthin Oleoresin, Beadlets, Whole Biomass Powder, Water Dispersible Powder)

Astaxanthin Bulk Finished Products (Capsules/Softgels, Tablets, Liquid Formulations)

  • Haematococcus Pluvialis Market Assessment -- by Application

Nutraceuticals & Dietary Supplements

Aquaculture & Animal Feed

Cosmetics & Personal Care

Food & Beverages

Pharmaceuticals

  • Haematococcus Pluvialis Market Assessment -- by Geography

North America (U.S., Canada)

Europe (Germany, U.K., France, Italy, Spain, Netherlands, Denmark, Sweden, Rest of Europe)

Asia-Pacific (China, Japan, India, South Korea, Australia, Vietnam, Rest of Asia-Pacific)

Latin America (Brazil, Mexico, Argentina, Rest of Latin America)

Middle East & Africa (Israel, Egypt, Saudi Arabia, South Africa, UAE, Rest of Middle East & Africa)

TABLE OF CONTENTS

1. Introduction

  • 1.1 Market Definition
  • 1.2 Market Ecosystem
  • 1.3 Currency and Limitations
    • 1.3.1 Currency
    • 1.3.2 Limitations
  • 1.4 Key Stakeholders

2. Research Methodology

  • 2.1 Research Approach
  • 2.2 Data Collection & Validation Process
    • 2.2.1 Secondary Research
    • 2.2.2 Primary Research & Validation
      • 2.2.2.1 Primary Interviews with Experts
      • 2.2.2.2 Approaches for Country-/Region-Level Analysis
  • 2.3 Market Estimation
    • 2.3.1 Bottom-Up Approach
    • 2.3.2 Top-Down Approach
    • 2.3.3 Growth Forecast
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

3. Executive Summary

  • 3.1 Overview
  • 3.2 Market Analysis, by Product
  • 3.3 Market Analysis, by Application
  • 3.4 Market Analysis, by Geography
  • 3.5 Competitive Analysis

4. Market Insights

  • 4.1 Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Natural Astaxanthin in Nutraceuticals and Dietary Supplements
    • 4.2.2 Growing Demand for Natural Food Colorants and Clean-Label Ingredients
    • 4.2.3 Rising Adoption of Natural Astaxanthin in Aquaculture and Animal Nutrition
    • 4.2.4 Expanding Cosmetic Applications Driven by Anti-Aging and UV-Protection Properties
    • 4.2.5 Growing Research Supporting Astaxanthin's Health Benefits
  • 4.3 Market Restraints
    • 4.3.1 High Production Costs of Natural Astaxanthin
    • 4.3.2 Complex Cultivation and Extraction Processes
  • 4.4 Market Opportunities
    • 4.4.1 Advances in Photobioreactor Cultivation Technologies
    • 4.4.2 Expanding Applications in Functional Foods and Beverages
    • 4.4.3 Growing Demand for Natural Ingredients in Cosmetics and Personal Care
  • 4.5 Market Challenges
    • 4.5.1 Competition from Synthetic Astaxanthin in Aquaculture Applications
    • 4.5.2 Supply Chain Constraints and Production Scalability
  • 4.6 Market Trends
    • 4.6.1 Expansion of Closed Photobioreactor Production Systems
    • 4.6.2 Development of Microencapsulation and Stabilization Technologies
    • 4.6.3 Rising Demand for Natural Astaxanthin in Sports Nutrition
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Threat of New Entrants
    • 4.7.2 Bargaining Power of Suppliers
    • 4.7.3 Bargaining Power of Buyers
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Competitive Rivalry
  • 4.8 Value Chain Analysis
    • 4.8.1 Strain Development and Inoculum Preparation
    • 4.8.2 Cultivation (Open Ponds, Closed PBR Systems)
    • 4.8.3 Harvesting and Biomass Processing
    • 4.8.4 Astaxanthin Extraction and Purification
    • 4.8.5 Formulation and Packaging
    • 4.8.6 Distribution and End-Use Applications

5. Haematococcus Pluvialis Market Assessment-by Product

  • 5.1 Overview
  • 5.2 Astaxanthin Ingredients
    • 5.2.1 Astaxanthin Oleoresin
    • 5.2.2 Beadlets
    • 5.2.3 Biomass Powder
    • 5.2.4 Water-Dispersible Powder
  • 5.3 Astaxanthin Finished Formulations
    • 5.3.1 Capsules / Softgels
    • 5.3.2 Tablets
    • 5.3.3 Liquid Formulations

6. Haematococcus Pluvialis Market Assessment-by Application

  • 6.1 Overview
  • 6.2 Nutraceuticals & Dietary Supplements
  • 6.3 Aquaculture & Animal Feed
  • 6.4 Cosmetics & Personal Care
  • 6.5 Food & Beverages
  • 6.6 Pharmaceuticals

7. Haematococcus Pluvialis Market Assessment-by Geography

  • 7.1 Overview
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Netherlands
    • 7.3.7 Denmark
    • 7.3.8 Sweden
    • 7.3.9 Rest of Europe
  • 7.4 Asia-Pacific
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Vietnam
    • 7.4.7 Rest of Asia-Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 Middle East & Africa
    • 7.6.1 Israel
    • 7.6.2 Egypt
    • 7.6.3 Saudi Arabia
    • 7.6.4 South Africa
    • 7.6.5 UAE
    • 7.6.6 Rest of Middle East & Africa

8. Competitive Landscape

  • 8.1 Overview
  • 8.2 Key Growth Strategies
  • 8.3 Competitive Benchmarking
  • 8.4 Competitive Dashboard
    • 8.4.1 Industry Leaders
    • 8.4.2 Market Differentiators
    • 8.4.3 Vanguards
    • 8.4.4 Emerging Companies
  • 8.5 Market Share Analysis

9. Company Profiles

  • 9.1 E.I.D.-Parry (India) Limited / Parry Nutraceuticals
  • 9.2 Cyanotech Corporation
  • 9.3 AstaReal Group / Fuji Chemical Industries
  • 9.4 Algatech Ltd. (Solabia Group)
  • 9.5 Algalif Iceland ehf.
  • 9.6 Beijing Gingko Group (BGG)
  • 9.7 Yunnan Alphy Biotech Co., Ltd.
  • 9.8 Yunnan Green A Biological Project Co., Ltd.
  • 9.9 Tianjin Norland Biotech Co., Ltd.
  • 9.10 Sun Chlorella Corporation
  • 9.11 BDI BioLife Science GmbH
  • 9.12 Atacama Bio Natural Products S.A.
  • 9.13 Shaivaa Algaetech LLP
  • 9.14 PIVEG, Inc.
  • 9.15 Others

10. Appendix

  • 10.1 Available Customization
  • 10.2 Related Reports